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The study of normal mammalian cell growth and the defects that contribute to disease pathogenesis links
metabolism to cell growth. Here, we visit several aspects of growth-promoting metabolism, emphasizing
recent advances in our understanding of how alterations in glucose metabolism affect cytosolic and mito-
chondrial redox potential and ATP generation. These alterations drive cell proliferation not only through sup-
porting biosynthesis, energy metabolism, and maintaining redox potential but also through initiating
signaling mechanisms that are still poorly characterized. The evolutionary basis of these additional layers
of growth control is also discussed.A renewed interest in research in cellular metabolism has collab-
orated with advances in analytical technologies and computa-
tional methodologies to yield rapid conceptual breakthroughs
in our modern understanding of metabolic regulation in cellular
systems (McKnight, 2010). One area of rapid progress involves
the regulation of mammalian cell growth and the defects in this
regulation that can lead to proliferative diseases such as cancer
(DeBerardinis et al., 2008; Hsu and Sabatini, 2008; Levine and
Puzio-Kuter, 2010; Luo et al., 2009; Vander Heiden et al.,
2009). It has long been realized that cells undergoing rapid
growth and division exhibit changes in metabolism (Warburg,
1956). However, accumulating evidence indicates that alter-
ations inmetabolism are necessary, and in some cases sufficient
for cell growth. Moreover, the same signal transduction path-
ways that coordinate the activation of transcription factors and
cell-cycle progression control and are controlled by changes in
cellular metabolism (Jones and Thompson, 2009; Levine and
Puzio-Kuter, 2010; Shaw and Cantley, 2006; Vander Heiden
et al., 2009). In this review,wewill discuss aspects ofmetabolism
in the context of cell growth, emphasizing recent advances in our
understanding of glucose metabolism and how they affect out
understanding of redox potential, energy status, biosynthesis,
and signal transduction in growing cells.
The Warburg Effect and Cell Growth
Alterations in cellular glucose metabolism are now recognized to
constitute a common feature of themajority of tumor cells (Hana-
han and Weinberg, 2011). In a series of papers describing the
original experiments, Otto Warburg showed that tumor cells
were metabolizing glucose to lactate and that this process,
referred to as aerobic glycolysis, was occurring in the presence
of oxygen (Warburg, 1925, 1956; Warburg et al., 1924; Wein-
house, 1976). In addition to the preferential utilization of fermen-
tation was the observation that tumor cells also exhibited
a substantially enhanced rate of glucose uptake. The quantifica-
tion obtained from these experiments indicated that tumor cells
could metabolize many orders of magnitude larger amounts of
glucose than their differentiated, normal counterparts (Warburget al., 1927). That is, in Warburg’s initial estimation, the amount
of glucose being metabolized in a tumor per unit time is on the
same order as the amount being metabolized through entire
regions of the circulatory system comprising multiple organs.
Although this form of metabolism was identified in solid tumors,
its features also provide insights into understanding general
mechanisms of cell growth.
Why cancer cells and growing cells utilize fermentative meta-
bolism is complicated and remains a hotly contested topic. One
reason for the controversy is that the origins and growth-
promoting functions of the Warburg effect are pleiotropic and
include multiple, evolutionarily conserved cell-autonomous
functions observed even in yeast (Brauer et al., 2008). These
functions include the support of biosynthetic programs as well
as the maintenance of redox, energy, and other chemical poten-
tials. In addition, such a cell-autonomous metabolism functions
to initiate signal transduction mechanisms that confer additional
layers of growth-regulatory properties to cells. Each of these
functions will be discussed below.
In addition to the cell-autonomous biological functions, non-
cell-autonomous effects may result in growth-advantageous
tumor-stroma and other cell-cell interactions (Gatenby and
Gillies, 2004). These non-cell-autonomous effects include the
ability of lactate, by acidification, to facilitate the disruption of
tissue architecture and thus promote tumor cell invasion (Parks
et al., 2011). Acidification of the tumor microenvironment may
also promote immune evasion (Gatenby and Gillies, 2008). For
example, cell migration has a pH dependence and in addition,
some chemokines and cytokinesmay be preferentially degraded
under acidic conditions. Nevertheless, despite the complex
aspects of the benefits of tumor cell fermentation on non-cell-
autonomous cell growth, the consequences of enhanced
glucose uptake and fermentation have many cell-autonomous
growth advantages.
High Glucose Uptake and Cell growth
The many orders of magnitude per cell difference in the rate of
glucose uptake has been translated to the clinic, and positronCell Metabolism 14, October 5, 2011 ª2011 Elsevier Inc. 443
Figure 1. Glucose Metabolism during
Conditions of High and LowGlucoseUptake
In conditions of low glucose uptake and flux
through glycolysis (left), the glucose flux that
passes through glycolysis and generates NADH is
balanced by amitochondrial shuttlingmechanism.
In conditions of high glucose uptake and flux
(right), the capacity of the malate-aspartate shuttle
to regenerate NAD+ can be saturated and lactate
dehydrogenase activity is required to regenerate
NAD+. A proposition is that this behavior can
explain the Warburg effect. The thickness of the
arrows represents relative magnitudes of flux at
different points in the glycolytic pathway. Inset:
The malate-aspartate shuttle: a series of oxida-
tion-reduction reactions and antiporter-based
trafficking of intermediate metabolites that begins
with the oxidation of malate and ends with
reduction of aspartate in a set of six reactions.
Directed arrows denote the conversion of sub-
strate to product. The net result is a regeneration
of NAD+ in the cytosol and production of NADH in
the mitochondria. MAL, malate; ASP, aspartate;
aKG, alpha-ketoglutarate; OAA, oxaloacetate;
and GLU, glutamate.
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routinely used to monitor and classify tumors (Engelman et al.,
2008; Strauss and Conti, 1991). This difference in glucose
metabolism also has far-reaching consequences concerning
the rearrangements of metabolic fluxes that occur downstream
of glucose capture.
Some of the implications of the high glycolytic rates observed
in growing cells can be observed from the chemical equation for
glycolysis in which onemolecule of glucose is converted into two
molecules of pyruvate:
C6H12O6 + 2Pi + 2ADP+ 2NAD
+/2C3H3O3 + 2H2O
+ 2ATP+ 2NADH:
In addition to the generation of pyruvate, twomolecules of ATP
and two molecules of the reduced form of Nicotinimide Adenine
Dinucleotide (NAD) are generated. Thus, for glycolysis to be
maintained, a flux balance that consumes its products must be
achieved. This mass conservation requires a supply of glucose
and inorganic phosphate as well as sufficient consumption of
both ATP and NADH.444 Cell Metabolism 14, October 5, 2011 ª2011 Elsevier Inc.Alterations in Redox Potential
and Cell Growth
In terminally differentiated cells or other
cell types undergoing low rates of
glycolysis, regeneration of NAD+ from
NADH resulting from the end product
of glycolysis is achieved by redox-
coupled mitochondrial shuttles (LaNoue
and Williamson, 1971). Such shuttles
involve themovement of oxidizable mate-
rial between subcellular compartments.
These processes are accomplished by
antiporter-based mechanisms by which
the transport of one metabolite from one
compartment to another requires theconcomitant transport of an additional metabolite from the
receiving compartment back into the exiting compartment.
The most commonly appreciated shuttle is known as the
malate-aspartate shuttle (LaNoue and Williamson, 1971). Other
shuttles such as the glycerol phosphate shuttle may also play
a role and others may yet be discovered. Additional shuttles
may couple redox potential to other organelles such as the
peroxisome and lysosome.
In the malate-aspartate shuttle (Figure 1), cytosolic oxaloace-
tate (OAA) is first reduced to form malate (MAL) and in the
process, NAD+ is generated from NADH, eliminating the cyto-
solic NADH/NAD+ imbalance that results from glycolysis. MAL
enters the mitochondria through an antiporter mechanism
coupled to mitochondrial alpha-ketoglutarate (aKG) export to
the cytosol. Upon entering the mitochondria, MAL is oxidized
and converted back to OAA, thereby generating NADH in the
mitochondria. By a transamination reaction, OAA is then con-
verted to aspartic acid (ASP) with the nitrogen donor glutamate
converted back to aKG. ASP is then transported from the mito-
chondria to the cytosol in exchange for cytosolic GLU by another
antiporter. OAA is then generated in the cytosol from the
Figure 2. A Mathematical Model Characterizing the Effects of Lactate Production on Changes in Glucose Uptake and NAD+ Regeneration
Rates
Left: A model that considers the stoichiometric balance of carbon and NAD+/NADH-generating fluxes in glycolysis and peripheral metabolism. In the model,
glucose uptake and capture resulting in the generation of 2 glycolytic carbon units occurs at a rate, Jin. Glucose ismetabolized through a series of steps eventually
reaching an intermediate dihydroxyacetone phosphate (DHAP), at which point it is oxidized to produce NADH from NAD+. Eventually, a glycolytic carbon unit
reaches pyruvate, where it can be reduced to produce lactate and generate NAD+ from NADH at a rate, JL. Alternatively, pyruvate can enter the mitochondria at
a rate JOx. External to glycolysis, NAD
+ is regenerated from NADH by redox shuttles and other mechanisms. As a result, two differential equations can be written
describingmass conservation of carbon and redox status and, at steady-state, can be solved for the relative rate of JL over JOx, which is ameasure of the extent of
the Warburg effect or relative glucose-derived lactate production (in blue). Right: A representative plot of the ratio of the rate of lactate production to the rate of
pyruvate entry into themitochondria as a function of glucose uptake andNAD+ regeneration rate is shown. The extent of theWarburg effect is thus proportional to
the rate of glucose uptake and inversely proportional to the rate at which NAD+ is regenerated by sources outside of lactate dehydrogenase. The straight line
represents an estimated rate of NAD+ from shuttles such as the malate-aspartate shuttle that is limited by mitochondrial transport rates. As glucose uptake
increases (in the direction of the arrow on x axis), the relative amount of glycolytic flux diverted to lactate production increases. As the rate at which NAD+ is
regenerated increases (in the direction of the arrow on the y axis), the relative amount of glycolytic flux diverted to lactate production decreases. These equations
are obtained strictly from mass conservation of a model involving glucose entering glycolysis and leaving as either pyruvate or lactate. If the model allows for
carbon units to exit glycolysis, then this would result in lowering the effective Jin in the equation.
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converts cytosolic GLU to aKG. This reaction completes the
cycle and the net result is that NADH is converted back to
NAD+ in the cytosol and NAD+ is converted to NADH in the mito-
chondria with no net flux in any other metabolite. The NADH to
NAD+ conversion in the cytosol satisfies the redox imbalance
from glycolysis and the NADH generated in the mitochondria
enters the electron transport system to ultimately generate
more ATP.
A similar concept is in place with the glycerol phosphate
shuttle in which glycerol-3-phosphate is shuttled into the mito-
chondria and the net result of the process involves the regenera-
tionofNAD+ fromNADH in thecytosol andproductionof reducing
equivalents for oxidative phosphorylation this time in the form of
FADH2. Flux through the glycerol phosphate shuttle is thought
to occur primarily in brown fat, but its generality remains unex-
plored, and it is tempting to speculate that this activity could be
upregulated in tumors (Kozak et al., 1991). Although these
redox-coupled shuttling pathways were worked out many years
ago, much remains to be learned about their regulation and how
the fluxes across the compartments are controlled.
For small rates of glycolysis (Figures 1 and 2), calculations
predict that these shuttles are able to account for the production
of NAD+ to balance the rate at which NADH is generated. This
behavior is in contrast to the case of high glucose uptake
when the rate of NADH generation increases by many ordersofmagnitude compared to the rate observed under normal phys-
iological conditions and thus typically exceeds the capacity of
these relative slowmitochondrial shuttles (Figure 2). It is not likely
that these shuttles can regenerate sufficient NAD+ when trans-
port across intracellular membranes approaches its maximum
velocity. Therefore, at the rates of glycolysis observed in rapidly
dividing cells, these shuttling mechanisms are likely saturated.
As a result, other mechanisms are required to regenerate cyto-
solic NAD+. The major mechanism that is in place to regenerate
NAD+ involves the reduction of pyruvate to lactate to generate
NAD+ from NADH via lactate dehydrogenase (LDH) (Figure 2).
LDH is frequently overexpressed in growing cells, and this effect
allows for an increasedmaximum enzyme velocity to account for
the enhanced requirement for NAD+ regeneration. As a result,
the maintenance of high rates of glycolysis and the concomitant
requirement of NAD+ regeneration may, to a large extent, induce
the Warburg effect in growing cells (Figure 2).
The cytosolic ratio of NAD+ to NADH appears greater than
one in measured cases and this is observed even in rapidly
proliferating transformed cells that undergo high rates of glycol-
ysis (Schwartz et al., 1974). The advantages of a positive oxida-
tive redox potential (high NAD+/NADH ratio) are many (Lin and
Guarente, 2003). These effects include signaling functions
through, for example, NAD+-dependent ADP-ribosylation by
PARP enzymes that are essential for DNA repair and survival
and NAD+-dependent deacetylases (sirtuins) that play criticalCell Metabolism 14, October 5, 2011 ª2011 Elsevier Inc. 445
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Additionally, such a redox potential promotes biosynthesis and
will be discussed later.
ATP Requirements for Cell Growth and the Existence
of High-Energy Phosphate-Consuming Futile Cycles
Aerobic glycolysis is an inefficient means of generating ATP with
nearly 20-fold less ATP generated per unit of glucose than the
amount that can be produced through complete oxidation of
glucose to CO2 in the mitochondria. In addition, other materials
can be utilized in the mitochondria for ATP generation. These
catabolites include amino acids such as glutamine as well as
long-chain fatty acids (DeBerardinis et al., 2008; Hsu and Saba-
tini, 2008; Locasale and Cantley, 2010; Schafer et al., 2009).
However, the rate of glucose uptake in growing cells is often
many orders of magnitude larger than that observed in cells
comprising nongrowing, differentiated tissue (Warburg et al.,
1927). Taking this into account the overall Warburg effect
(enhanced glucose uptake accompanied by fermentation) could
potentially generate more ATP.
Surprisingly, calculations suggest that the amount of ATP
required for mammalian cell growth and division may be far
less than that required for basal cellular maintenance (Kilburn
et al., 1969). That is, in the time that it takes to undergo growth
and cell division, the amount of ATP consumed in processes
such as the maintenance of ion gradients via Na+/K+ and Ca2+
ATPases, steady-state protein and RNA synthesis, and intracel-
lular trafficking exceeds the amount used for the de novo
synthesis of biomaterials that constitute a new cell.
If it is counterintuitive that ATP is not the limiting reagent for cell
growth and division, several illustrative examples are helpful. For
example, one of the major energetic costs of biosynthesis is the
creation of the peptide bonds that comprise polypeptide chain
polymerization leading to protein synthesis. In fact, each peptide
bond carries an energetic cost of about 3 kcal/mol. However,
studies have shown that protein turnover is typically rapid in
cells. Proteome-wide studies of global protein turnover rates in
exponentially growing mammalian cells have been measured
using fluorescence-based photo bleaching techniques (Eden
et al., 2011). It was found that the half-lives of most proteins
range from minutes to a few hours. Only about 10% of proteins
within the proteome had half-lives close to the time scales corre-
sponding to cell cycle turnover. Thus the majority of ATP
consumed during protein synthesis occurs to maintain steady-
state levels of protein concentrations and not for the production
of protein to constitute a new cell.
In the case of the Na+/K+ ATPase pump, one molecule of ATP
is consumed for every three Na+ ions that are pumped out of cells
to maintain approximately a 20 mM concentration in the cytosol.
Measurements of the rate of ion flux have been observed to be
around 100 nM/min per milligram of protein (Soltoff et al.,
1988). Glucose uptake rates in cultured cells are on that order
as well. For example, transformed NIH 3T3 fibroblasts have
a measured glucose uptake rate to also be around 100 nM/min
per milligram of protein (Peterkofsky and Prather, 1982). Thus
the amount of ATP consumed by the Na+/K+ ATPase pump is
comparable to the amount generated by glycolysis. Therefore,
the generation of ATP by increased glycolysis might far exceed
the additional ATP requirements for proliferation.446 Cell Metabolism 14, October 5, 2011 ª2011 Elsevier Inc.Furthermore this amount of ATP generation could be inhibitory
for growth due tomany factors. One effect of excess ATP directly
on the glycolytic pathway is the inhibition of glycolysis by allo-
steric inhibition of phosphofructokinase. Other overall effects
involve the toxicities associated with a change in the equilibrium
of ATP-dependent cellular reactions. In fact, much of the histor-
ical discussion of the Warburg effect concerned how highly
glycolytic cells compensate for excess ATP.
Efraim Racker noted this problem of an imbalance of ATP-
generating and ATP-consuming processes in glycolytic cells
and postulated that large ATP-consuming fluxes must be upre-
gulated to account for the increase in ATP production (Racker,
1976; Scholnick et al., 1973; Soltoff et al., 1988). For example,
there was considerable effort spent on searching for a lesion in
the Na+/K+ ATPase pump that would decouple ion transport
from ATP hydrolysis. Recently, other mechanisms of upregulat-
ing ATP hydrolysis have been identified. It has been shown
recently that increasing the rates of ATP consumption at the
endoplasmic reticulum results in higher rates of aerobic glycol-
ysis (Fang et al., 2010). This phenomenon appears to a large
extent to occur in the absence of the PTEN tumor suppressor
gene.
One clue for how cells might compensate for enhanced rates
of ATP production came from the observation that growing cells
express a single isoform of pyruvate kinase, PKM2 (Christofk
et al., 2008a; Eigenbrodt et al., 1992). This expression is in
contrast to the form of pyruvate kinase observed in differentiated
cells, PKM1. Pyruvate kinase catalyzes the final step of glycol-
ysis converting phosphoenolpyruvate (PEP) to pyruvate and
transferring a phosphate to ADP to regenerate ATP. Bio-
chemically, PKM2 is intrinsically a less active enzyme with
a specific activity of about one half that of PKM1. In addition,
PKM2 is subject to several forms of negative regulation including
the inhibition of its activity via phosphotyrosine-mediated
binding (Christofk et al., 2008b). However, when cells were engi-
neered to express exclusively the PKM1 or PKM2 isoforms,
enhanced lactate production was observed in cells expressing
PKM2. This observation raised many questions as it was unclear
why a less active enzyme would generate more lactate.
A partial resolution to this paradox was the discovery of an
alternate enzymatic activity for the pyruvate kinase substrate,
PEP (Figure 3) (Locasale et al., 2010; Vander Heiden et al.,
2010). In cells expressing PKM2, an enzymatic activity was
discovered that converted PEP to pyruvate without generating
ATP. This activity also mediated transfer of the phosphate group
from PEP to the active site of phosphoglycerate mutase (PGAM).
PGAM catalyzes an intermediate step of glycolysis involving
a mutase reaction that transfers a phosphate from the three to
the two position of the glycerate moiety. This enzymatic activity
could be purified away from pyruvate kinase as well as enolase,
the enzyme catalyzing the conversion of 2-phosphosphoglycer-
ate to PEP. Quantitatively, it was shown that this mechanism
could result in up to one-half of the total pyruvate generated
from PEP implying that this mechanism could be an important
source of lactate. While the exact enzyme mechanism involved
in the phosphotransfer is unclear, it was shown that this reaction
occurred at a concentration commensurate with the Michaelis
constant of pyruvate kinase. Accompanying the phosphotrans-
fer was the generation of pyruvate as well as the release of
Figure 3. Alternative Glycolytic Pathway that Decouples Glycolysis
from ATP Synthesis
A glycolytic phosphate futile cycle that is initiated when 3-phosphoglycerate is
converted to 2-phosphoglycerate by phosphoglycerate mutase. The reaction
proceeds through a 2,3-diphosphoglycerate (2,3DPG) intermediate that has
a tendency to dissociate from phosphoglycerate mutase and release an
inorganic phosphate. 2-phosphoglycerate is converted to phosphoenolpy-
ruvate by enolase. Two enzyme activities compete for phosphoenolpyruvate
as a substrate. One activity (left) involves pyruvate kinase that transfers the
phosphate group to ADP to generate pyruvate and ATP. The other involves an
enzyme complex that donates the phosphate to phosphoglycerate mutase to
prime the enzyme active site (right). In turn, this alternate glycolytic pathway
results in net zero production of ATP during glycolysis.
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the protein initiates a PEP-dependent feedback loop that may
have some additional regulatory properties. The net reaction is
a phosphate-burning futile cycle in which pyruvate is generated
in the absence of ATP production from glycolysis. This decou-
pling of glycolysis from ATP synthesis may confer multiple
growth-advantages to cells by limiting the availability of ATP.
Additional biological functions of this futile cycle remain to be
discovered and how this cycle alters glycolytic flux remains to
be studied.
Biosynthesis and Cell Growth
The biosynthetic requirements of growing cells involve de novo
synthesis of nucleotide, membrane, and protein components.
These materials can originate from central carbon metabolism
as well as salvage pathways located in peripheral metabolism.
Enhanced flux into biosynthetic pathways is achieved in condi-
tions of high glucose uptake. When cells exhibit multiple orders
of magnitude of enhanced glucose uptake, fluxes of glucose
into biosynthetic pathways are dramatically altered. Under these
conditions, even if only 0.1%–1% of the glucose that is captured
enters biosynthetic pathways such as the pentose phosphate
pathway, glycerolipid metabolism, or de novo amino acid
biosynthesis, this increase can more than double the basal flux
into these pathways compared to the flux in nontransformed
cells.
Increases in the rates of NADH generation from glycolysis can
drive reductive fluxes through for example, glycerol 3-phosphate
dehydrogenase, which utilizes NADH to generate glycerol-3-phosphate from dihydroxy acetone phosphate (DHAP). Glyc-
erol-3-phosphate is required for synthesis of all the glycerol-
backbone lipids. Changes in DHAP and NADH concentrations
can result in a transition of glycerol phosphate dehydrogenase
operating in a kinetic regime in which catalysis is limited by the
availability of its substrate up to a regime where the enzyme
kinetics are saturated and the enzyme kinetics operate at
maximum velocity.
In addition to the high rates of glucose flux that contribute to
glycolytic intermediates that could be used to divert glycolytic
flux out of glycolysis from any one of the ten glycolytic interme-
diates, enhanced glucose flux may also function to reorganize
mitochondrial flux that contributes to biosynthesis. Within the
mitochondria, the tricarboxylic-acid (TCA) based carbon sour-
ces that cycle in the mitochondria to contribute electrons to
the electron transport chain are also reactive with enzymes
that initiate specific biosynthetic programs (DeBerardinis et al.,
2007). How enhanced rates of glucose uptake affect mitochon-
drial biosynthetic functions are unclear but many lines of
evidence suggest an essential coupling.
For example, the redox potential in the mitochondria that sets
the relative fluxes and steady-state concentrations of TCA cycle
intermediates could be regulated by glycolysis and the malate-
aspartate and glycerol-phosphate shuttles as well as by the
rate of glucose-derived carbon entry into the mitochondria. In
principle, changes in the redox coupling could direct TCA cycle
flux differentially into any of the biosynthetic routes beginning at
the TCA cycle. One possibility would be a buildup of acetyl-coA
that could be used for enhanced rates of de novo lipid biosyn-
thesis required in growing cells. A change in the mitochondrial
redox potential might allow for metabolites such as glutamine
to enter the mitochondria and redirect this carbon source into
nucleotide and lipid metabolism.
In addition to these biosynthetic functions, alterations in mito-
chondrial redox potential also affect the generation of reactive
oxygen species (ROS) (Finkel and Holbrook, 2000). Changes in
NADH and FADH2 levels affect the efficiency of electron trans-
port through electron transport complexes. Leaky electron
transfer is implicated in the generation of superoxides that
produce hydrogen peroxide. The generation of free radicals
has direct biochemical effects on growth signaling. For example,
ROS may enhance signal transduction through the inactivation
of phosphatases that have catalytic cysteine residues, such as
PTEN or protein tyrosine phosphatases, thereby enhancing
phosphoinositide 3-kinase and protein-Tyr kinase signaling
(Salmeen and Barford, 2005). Metabolic enzymes such as
glyceraldehyde-3-phosphate dehydrogenase are also inhibited
by ROS. Thus the generation of ROS can result in a multitude
of biological consequences.
Metabolism and Growth Signaling
Cellular decision-making occurs through signal transduction.
The signal transduction involved in mammalian cell growth has
largely been studied by examining the propagation of signals
through networks with information conveyed through modifica-
tions in the form of reversible phosphorylation at serine, threo-
nine, tyrosine residues, and inositol lipids. Networks of protein
phosphorylation events embedded in cascades with multiple
layers of nonlinear regulation such as crosstalk and feedbackCell Metabolism 14, October 5, 2011 ª2011 Elsevier Inc. 447
Figure 4. Regulation of Growth Signaling by Protein
Phosphorylation and Metabolism
Modes of mammalian signal transduction. Examples of modifications,
enzymes, substrates and the primary form of regulation are shown. OGT,
O-linked N-acetylglucosamine transferase; GLCNAC, N-acetylglucosamine;
PARP, Poly (ADP-ribose) polymerase; SAM, S-adenosylmethionine.
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pathways include the Ras-MAPK pathway and the PI3K-mTOR
pathways (Shaw and Cantley, 2006).
For signaling flux to propagate at any individual node, both
sufficient enzyme activity and metabolic substrate availability
are required. In the case of phosphorylation by protein kinases,
the metabolic substrate is ATP. Typical concentrations of inter-
cellular ATP are near 5 mM, and this value is far above the
Michaelis constant for most protein kinases. This implies that
enzyme activity of protein kinases is not affected by the avail-
ability of its metabolic substrate since cells rarely, if ever, see
the concentration of ATP that is necessary to affect signaling.
Instead, the regulation of signaling responses is generated
through the complexity of the networks involving over 500 indi-
vidual protein kinases and the different ways to activate them
(Yaffe et al., 2001).
These networks involve numerous regulatory mechanisms
such as the presence of cascades and feedback loops that
confer diverse properties to signal transduction networks. For
example, phosphorylation at a kinase activation loop by an
upstream kinase in the network or binding of a kinase to a
scaffold can alter the enzyme activity by varying its kinetic para-
meters by many orders of magnitude (Locasale et al., 2007). As
a result, these protein kinase networks can respond to diverse
environmental perturbations, including alterations in cellular
osmotic pressure, salt concentrations, ATP availability, the
presence of growth factors, and the availability of nutrients. In
contrast to mammalian cells, primitive organisms including most
prokaryotes lack these evolutionarily advanced protein kinase
signaling networks (Parkinson, 1993). Instead these organisms
integrate signals to make phenotypic decisions based on the
status of cellular metabolism (Kolb et al., 1993; Ptashne, 1988).
In spite of the regulatory power garnered by protein kinase
networks, other reversible protein posttranslation modifications
are increasingly becoming appreciated as having important roles
in cellular signal transduction. These modifications include pro-
tein acetylation, methylation, O-linked glcNAC-ylation, ADP-
ribosylation, and many others (Figure 4) (D’Amours et al., 1999;448 Cell Metabolism 14, October 5, 2011 ª2011 Elsevier Inc.Hart, 1997; Johnson, 2004; Roth et al., 2001; Teperino et al.,
2010). Many of these modifications are conserved down to the
level of prokaryotes. Current estimates from advances in mass
spectrometry-based proteomics suggest that many of these
modifications may be as prevalent in mammalian systems as
the more studied phosphorylation (Choudhary et al., 2009).
In contrast to reversible protein phosphorylation, each of these
modifications is carried out by a relatively small number of
enzymes. Thenumberofdistinct acetyltransferases,methy trans-
ferases, GlcNAc transferases, ADP-ribosyltransferases, etc., is
much smaller than the total number of unique protein kinases.
Also, in contrast to the case of protein kinases, where physiolog-
ical concentrations of the substrate ATP far exceed theMichaelis
constant, the enzymes that carry out thesemodifications typically
have Michaelis constants for their metabolic substrates that
are close to the physiological concentrations. These substrates
include acetyl-CoA, S-adenosylmethionine, N-acetylglucos-
amine, and ADP-ribose, and their levels are dynamically regu-
lated by alterations in cellular metabolism (Figure 4).
Changes in these concentrations can result from variations in
metabolic flux occurring from countless mechanisms such as
changes in nutrient uptake. These changes could affect their
concentrations by several orders of magnitude and in turn affect
activity of their corresponding enzymes by shifting the substrate
concentration to levels well above or below the Michaelis-
constant of the enzymes. Therefore, the diversity of signaling
responses regulated through these modifications may have
evolved from the ability of metabolic networks to adapt metabo-
lism to achieve differing levels of substrate availability. These
forms of signal transduction are more ancient than protein
kinases and have evolved from more primitive versions of signal
transduction observed in lower organisms.
Classic instances of metabolite-regulated signal transduction
involve the control of transcription factor activity by small mole-
cules—for example, degradation of hypoxia-inducible factor
(HIF) in response to prolyl hydroxylation (Ivan et al., 2001; Jaak-
kola et al., 2001). In this case, HIF is prolyl-hydroxlyated when
sufficient levels of O2 and alpha-ketoglutarate are available.
Also, the glucose-responsive transcription factor chREBP acti-
vates a program of genes in response to changes in glucose
concentration (Yamashita et al., 2001). Finally, the lipid-respon-
sive transcription factor SREBP regulates its activity in response
to intracellular cholesterol levels (Brown and Goldstein, 1997).
Such behavior is reminiscent of operons in bacteria that control
the transcription of genes in response availability of specific
nutrients.
Many other examples of metabolic signal transduction of this
form in mammalian systems have been described. For example,
changes in dietary folate intake have strong associations with
changes in methylation status in humans (Christensen et al.,
2010). It has also been shown that changes in glucose availability
and acetyl-CoA levels regulate epigenetic programs through
direct effects on the modification of acetylation patterns on
histones (Cai et al., 2011;Wellen et al., 2009). Another particularly
striking example of how altered metabolic flux may affect cell
growth through changes in signaling machinery was observed in
the hexosamine biosynthetic pathway. In the study by Wellen
and colleagues, the authors show that cells, when growth-
arrested upon deprivation of glucose, can regain the ability
Cell Metabolism
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recovery of cellular GlcNAc modifications that affect diverse
cellular processes is implicated in this rescue of cell growth.
Additional layers of feedback control also occur in the context
of metabolic regulation of signal transduction. For example, pro-
teomics studies have shown that protein acetylation is overrep-
resented on metabolic enzymes compared to other proteins
(Zhao et al., 2010). This observation creates possibilities that
feedback control of NAD+-mediated metabolic fluxes affects
the activity of deacetylases such as the Sirtuin family (Blander
and Guarente, 2004). However, the advantages of such feed-
back controls are unknown. Also, activation of Mammalian
Target of Rapamycin (mTOR) is mediated by amino acid avail-
ability in addition to protein kinase signaling (Wullschleger
et al., 2006). mTOR in turn stimulates a program of metabolic
changes manifested in the enhanced transcriptional activity of
metabolic genes (Du¨vel et al., 2010). As a result, enhanced levels
of lipids and amino acids could create positive feedback loops
that stimulate mTOR signaling and its growth-promoting func-
tions. As has been appreciated for many years, changes in lipid
metabolism and the ability of lipids to regulate the generation of
secondary messengers in signaling pathways also have essen-
tial roles in regulating cell growth (Kim et al., 2011; Nomura
et al., 2010; Riese et al., 2011).Summary and Future Directions
The ability of cells to sense changes in metabolism to control cell
growth is found in themost primitive of organisms. A selection for
this behavior may have been one of the first acquired processes
in the evolution of cell autonomy. Additional layers of growth
control, such as protein kinase networks evolved later and
expanded dramatically in the development of multicellular
organisms. These networks evolved to institute forms of cellular
social control to, for example, sense the presence of growth
factors secreted by other cells (Raff, 1992). In the development
of cancer, cells universally acquire mutations in these signaling
networks that allow them to proliferate outside the social context
of normal tissue development. However, the ability of these
cancer cells to regulate growth bymetabolism and nutrient avail-
ability remains. If metabolism then is the primary form of growth
control, a fundamental question that remains then is to what
extent are these cells now more sensitive to perturbations in
metabolism and nutrient availability.
Despite the many recent advances in understanding the
metabolism of growing cells in mammalian organisms, much
remains to be understood. How theWarburg effect and changes
in redox potential might contribute to enhanced or specific
anabolic metabolism has not been fully characterized and how
enhanced glycolysis may contribute to metabolically-regulated
signal transduction is still in its infancy. Also, how these behav-
iors depend on the genetic status within cells is not understood.
Nevertheless these areas of study provide a wealth of unan-
swered questions and addressing them may open up new ther-
apeutic strategies in the confrontation of proliferative diseases.ACKNOWLEDGMENTS
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